EP. 1: COVID-19s Impact on Patients and Care Providers
EP. 2: Overview of PAD: Epidemiology and Pathophysiology
EP. 3: Economic Burden of PAD and Community Awareness
EP. 4: PAD: Manifestations and Surgical Outcomes in Men vs Women
EP. 5: Nonpharmacologic Management of Peripheral Artery Disease
EP. 6: Managing PAD With Therapeutic Exercise Regimens
EP. 7: Antiplatelet Monotherapy and Dual Antiplatelet Therapy in PAD
EP. 8: Peripheral Arterial Disease: Improving Surgical Strategies
EP. 9: Peripheral Arterial Disease: Lipid-Lowering Strategies
EP. 10: Surgical Revascularization in Peripheral Arterial Disease
EP. 11: Considerations for Adding Novel Agents to Antiplatelet Therapy
EP. 12: Role of SGLT2 Inhibitors in Treating PAD
EP. 13: Evaluating the Role of Vascular Surgeons and Pharmacotherapy
EP. 14: Interpreting Data From the COMPASS and ATLAS ACS 2-TIMI 51 Trials
EP. 15: Antiplatelet Therapy in PAD: Interpreting Data From TWILIGHT
EP. 16: VOYAGER PAD: Clinical Rationale and Study Design
EP. 17: VOYAGER PAD: Study Results and Practical Implications
EP. 18: Real-World Applications of Trial Data in PAD
EP. 19: Peripheral Arterial Disease: Future Directions in Care
